In contrast, when using the traditional race-adjusted creatinine-based equation (eGFRcr-ASR), the HR was 2.8 (95% CI, 1.6–4.9 ...

For patients with CKD and T2D, combination finerenone plus empagliflozin leads to a greater reduction in the urinary albumin-to-creatinine ratio than either agent alone.

Phase II CONFIDENCE study data reveal that simultaneous initiation of Kerendia and Jardiance significantly improves UACR and ...

Prompt treatment with a drug combo can effectively manage chronic kidney disease in people with type 2 diabetes, a new ...

Simultaneous treatment start with finerenone and SGLT-2-inhibitor demonstrated positive data in patients with CKD associated with type 2 diabetes: Berlin Saturday, June 7, 2025, 1 ...

Adults with chronic kidney disease and type 2 diabetes had slower kidney function decline with a combination of the ...

The standard of care for managing patients with type 2 diabetes and CKD -- in addition to a healthy lifestyle -- has always ...

New data from the CONFIDENCE trial demonstrates that combination therapy with finerenone and empagliflozin leads to ...

Diabetic kidney disease, a major complication for those with diabetes, can be prevented through proactive measures. Optimal lifestyle management, including diet and exercise, alongside medications ...

Those with CKD receiving tirzepatide had larger urine albumin-to-creatinine ratio reductions. Perspective from M. Luiza Caramori, MD, MSc, PhD Adults with type 2 diabetes receiving tirzepatide had ...

Since diabetes can increase your risk of kidney ... nephropathy is through a pot urine test called the urine albumin-creatinine ratio. This test measures milligrams of albumin per gram of ...